Outlook Therapeutics (OTLK) Q1 2026 Earnings

17FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.54
-0.38
-0.22
-0.06

Details

Expected EPS
-0.226667
Actual EPS
-0.22
Surprise EPS
0.01
Surprise Percent
+2.94%

Description

Outlook Therapeutics (OTLK) has reported earnings of -0.22 per share for Q1 2026.

0 Comments

Share your thoughts